179 related articles for article (PubMed ID: 15751630)
21. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A
Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427
[TBL] [Abstract][Full Text] [Related]
22. Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in oral squamous cell carcinoma: possible markers as predictors of clinical outcome.
Sakakura K; Chikamatsu K; Shino M; Sakurai T; Furuya N
Acta Otolaryngol; 2006 Dec; 126(12):1295-302. PubMed ID: 17101591
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
[TBL] [Abstract][Full Text] [Related]
24. Effects of UFT on thymidylate synthase and dihydropyrimidine dehydrogenase activities in lung cancer.
Miyamoto H; Morio A; Izumi H; Yamazaki A; Wang Z; Futagawa T; Sonobe S
Anticancer Res; 2003; 23(5b):4153-6. PubMed ID: 14666617
[TBL] [Abstract][Full Text] [Related]
25. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
[TBL] [Abstract][Full Text] [Related]
26. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Komiyama H; Okano M
Gan To Kagaku Ryoho; 2002 Mar; 29(3):413-20. PubMed ID: 11915731
[TBL] [Abstract][Full Text] [Related]
27. Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues.
Kurebayashi J; Yamamoto Y; Udagawa K; Okubo S; Fukushima M; Sonoo H
Oncol Rep; 2004 May; 11(5):973-9. PubMed ID: 15069534
[TBL] [Abstract][Full Text] [Related]
28. Expression of dihydropyrimidine dehydrogenase in cancer cells but not in stromal cells predicts the efficacy of fluorouracil treatment in patients with gastric carcinoma.
Hisamitsu K; Tsujitani S; Yamaguchi K; Fukuda K; Konishi I; Kaibara N
Anticancer Res; 2004; 24(4):2495-501. PubMed ID: 15330204
[TBL] [Abstract][Full Text] [Related]
29. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
Fakhrejahani E; Miyamoto A; Tanigawa N
Cancer Chemother Pharmacol; 2007 Aug; 60(3):437-46. PubMed ID: 17377791
[TBL] [Abstract][Full Text] [Related]
30. Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer.
Nakayama Y; Inoue Y; Nagashima N; Katsuki T; Matsumoto K; Kadowaki K; Shibao K; Tsurudome Y; Hirata K; Sako T; Nagata N; Itoh H
Anticancer Res; 2005; 25(6A):3755-61. PubMed ID: 16302736
[TBL] [Abstract][Full Text] [Related]
31. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis.
Fukui Y; Oka T; Nagayama S; Danenberg PV; Danenberg KD; Fukushima M
Int J Mol Med; 2008 Dec; 22(6):709-16. PubMed ID: 19020767
[TBL] [Abstract][Full Text] [Related]
32. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study.
Kawasaki G; Yoshitomi I; Yanamoto S; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Dec; 94(6):717-23. PubMed ID: 12464897
[TBL] [Abstract][Full Text] [Related]
33. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
[TBL] [Abstract][Full Text] [Related]
34. [Activities of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with colorectal cancer].
Uehara M; Takahashi S; Takenaka A; Izumi H; Fujii K; Ikawa O; Miyata K; Iizuka R; Matsumura H; Kakihara N; Shono Y; Tsuchihashi H; Saisaka Y
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2035-41. PubMed ID: 11791381
[TBL] [Abstract][Full Text] [Related]
35. [Thymidine phosphorylase is correlated with DPD in colon cancer].
Hamaji M; Nishida T; Miyazaki S; Nishida Y
Gan To Kagaku Ryoho; 2003 Apr; 30(4):495-500. PubMed ID: 12722680
[TBL] [Abstract][Full Text] [Related]
36. In vitro sensitivity to platinum-derived drugs is associated with expression of thymidylate synthase and dihydropyrimidine dehydrogenase in human lung cancer.
Takizawa M; Kawakami K; Obata T; Matsumoto I; Ohta Y; Oda M; Sasaki T; Watanabe G
Oncol Rep; 2006 Jun; 15(6):1533-9. PubMed ID: 16685392
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers.
Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
Oncol Rep; 2004 May; 11(5):1045-51. PubMed ID: 15069545
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of TS-1 based treatment and expression of thymidylate synthase and dihydropyrimidine dehydrogenase on oral squamous cell carcinoma.
Obara S; Yamamoto K; Hosogai N; Yoshimura Y
Oral Oncol; 2005 Mar; 41(3):276-82. PubMed ID: 15743690
[TBL] [Abstract][Full Text] [Related]
39. [Clinical significance of TS and DPD activities in colorectal carcinoma as a predictive factor of UFT sensitivity].
Funahashi K; Koike J; Saito N; Miki T; Matsumoto H; Ryu M; Shiokawa H; Tokuyama T; Goto T; Teramoto T
Gan To Kagaku Ryoho; 2004 Feb; 31(2):189-93. PubMed ID: 14997749
[TBL] [Abstract][Full Text] [Related]
40. [Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in penile cancer].
Zhao F; Tang J; Gou HF; Li LH; Dong H; Chen Y; Cheng K; Ding J; Chen X; Men HT; Liu JY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):756-9. PubMed ID: 24325106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]